查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433306

全球神經血管栓塞器材市場 2023-2030

Global Neurovascular Embolization Devices Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030年），全球神經血管栓塞設備市場將以6.3%的CAGR成長。市場成長歸因於腦動脈瘤盛行率的增加以及與顱內動脈瘤相關的嚴重風險，例如認知功能永久性喪失和神經系統疾病。腦動脈瘤在所有年齡層的個體中同樣普遍，但 35 歲及以上的個體風險較高。根據腦動脈瘤基金會 (BAF) 的數據，估計美國有 670 萬人患有未破裂的腦動脈瘤，即每 50 人中就有 1 人患有未破裂腦動脈瘤。腦動脈瘤最常見於 35 至 60 歲的族群，但也可能發生在兒童。大多數動脈瘤是在 40 歲之後形成的。女性比男性更容易罹患腦動脈瘤（比例為 3:2）。所有這些因素都迫使製造商推出新穎和尖端的神經血管栓塞設備，並提高全球食品和藥物管理局 (FDA) 的許可。例如，2022 年 3 月，Artio Medical, Inc. 是一家為周邊血管、神經血管和心臟病學市場開發創新產品的醫療器械公司，其新一代周邊血管產品 solus gold 栓塞裝置獲得美國 FDA 批准。閉塞。

區隔市場前景

全球神經血管栓塞設備市場根據產品和最終用途進行區隔。根據產品，市場分為栓塞彈簧圈和分流裝置。此外，根據最終用途，市場分為醫院和專科診所。在最終用途中，醫院區隔市場預計將佔據相當大的市場佔有率，因為它易於獲得，提供靈活的調度選項，對生活方式忙碌、尋求快速有效治療的個人有吸引力。

預計栓塞線圈子區隔市場將在全球神經血管栓塞設備市場中佔據相當大的佔有率

在這些產品中，栓塞線圈子區隔市場預計將在全球神經血管栓塞設備市場中佔據相當大的佔有率，因為它可以治療以前被認為無法手術的腦動脈瘤。根據博蒙特健康系統發表的研究，小頸小動脈瘤的彈簧圈栓塞比寬頸大或巨大動脈瘤的栓塞效果更好。長期追蹤顯示，超過 80% 的動脈瘤經彈簧圈栓塞治療取得了永久性成功。行業市場參與者開發的用於治療神經系統疾病的產品的進步推動了市場的成長。例如，2023 年 7 月，波士頓科學公司推出了用於微創週邊栓塞手術的 Embold 軟線圈和填充線圈。同樣，2023 年 6 月，美國 FDA 批准了線圈。 Embold 線圈包含一個輸送機構，使用戶可以輕鬆拆卸線圈。

區域展望

全球神經血管栓塞器械市場根據地理位置進一步區隔，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，亞太地區預計將在全球市場中佔據顯著佔有率，因為人口老化加劇、神經系統疾病以及新興經濟體可支配收入的增加正在推動亞太地區的市場成長。

北美地區預計全球神經血管栓塞器材市場複合CAGR顯著成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。支持該區域市場成長的主要因素包括人口老化的加劇，腦動脈瘤、頸動脈狹窄和中風等神經血管疾病發病率的增加，這增加了北美對神經血管栓塞設備的需求。根據美國疾病管制與預防中心 (CDC) 的數據，到 2022 年，美國每年有超過 795,000 人中風。其中約 61 萬例為首次或新中風。約 185,000 例中風患者中，近四分之一的人曾經中風。大約 87.0% 的中風是缺血性中風，即流向大腦的血液受阻。美國每 40 秒就有一人中風。每 3 分 14 秒就有一人死於中風。

市場參與者展望

服務全球神經血管栓塞設備市場的主要公司包括 B. Braun Melsungen AG、Cerenovus Inc.、Medtronic plc、Stryker Corp. 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2023年1月，Fluidx Medical Technology, Inc.在與腦膜中動脈（MMA）栓塞相關的體內研究中發布了IMPASS栓塞裝置，可用於治療大腦表面的慢性硬膜下血腫（CSDH） 。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個區隔市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球神經血管栓塞器械市場的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵區隔市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依區隔
    • 依地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • B. Braun Melsungen AG
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Cerenovus Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Medtronic plc
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Stryker Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場區隔

  • 全球神經血管栓塞設備市場（依產品）
    • 栓塞彈簧圈
    • 分流裝置
  • 全球神經血管栓塞器械市場（依最終用途）
    • 醫院
    • 專科診所

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Acandis GmbH
  • Balt Extrusion SA
  • Boston Scientific Corp.
  • DePuy Synthes (Johnson & Johnson Services, Inc.)
  • Integra Lifesciences Holdings Corp.
  • MicroVention Inc.
  • Penumbra Inc.
  • Phenox GmbH
  • Resonetics LLC
  • Spartan Micro, Inc.
  • Terumo Medical Corp.
Product Code: OMR2027923

Global Neurovascular Embolization Devices Market Size, Share & Trends Analysis Report by Product (Embolic Coils and Flow Diversion Devices), and by End-Use (Hospitals and Specialty Clinics), Forecast Period (2023-2030)

The global neurovascular embolization devices market is anticipated to grow at a CAGR of 6.3% during the forecast period (2023-2030). The market growth is attributed to the increasing prevalence of cerebral aneurysms, and severe risks associated with intracranial aneurysms, such as permanent loss of cognitive functions and neurological disorders. Brain aneurysm is equally prevalent in individuals of all age groups, however individuals 35 years and above are at high risk. According to the Brain Aneurysm Foundation (BAF), an estimated 6.7 million people in the US have an unruptured brain aneurysm or 1 in 50 people. Brain aneurysms are most prevalent in people aged between 35 to 60 years, however it may occur in children as well. Most aneurysms is developed after the age of 40 years. Women are more likely than men to have a brain aneurysm (3:2 ratio). All these factors have compelled manufacturers to introduce novel and cutting-edge neurovascular embolization devices and rising Food and Drug Administration (FDA) clearance globally. For instance, in March 2022, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, received US FDA clearance for its solus gold embolization device, a next-generation product for peripheral vascular occlusion.

Segmental Outlook

The global neurovascular embolization devices market is segmented on the product, and end-use. Based on the product, the market is sub-segmented into embolic coils and flow diversion devices. Further, based on end-use, the market is sub-segmented into hospitals and specialty clinics. Among the end-use, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the easy availability, offer flexible scheduling options, appealing to individuals with busy lifestyles who are seeking quick and effective treatments.

Embolic Coils Sub-Segment is Anticipated to Hold a Considerable Share of the Global Neurovascular embolization devices Market

Among the products, the embolic coils sub-segment is expected to hold a considerable share of the global neurovascular embolization devices market, owing to the allowing treatment of cerebral aneurysms that previously were considered inoperable. As per the study published by Beaumont Health System, coil embolization of small aneurysms with small neck has better results than embolization of large or giant aneurysm with wide necks. Long term follow up has shown permanent success in more than 80% of aneurysms treated with coil embolization. The advancements in the products designed for the treatment of neurological disorders developed by the industry market players drive the growth of the market. For instance, in July 2023, Boston Scientific Corp., launched its Embold soft and packing coils for minimally invasive peripheral embolization procedures. Similarly, in June 2023, the US FDA cleared the coils. Embold coils contain a delivery mechanism that allows users to detach the coil easily.

Regional Outlook

The global neurovascular embolization devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market around the globe, owing to the growing aging population, neurological disorders, and the rising disposable income in emerging economies are driving the market growth in the Asia-Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Neurovascular Embolization Devices Market

Among all the regions, the North America region is anticipated to grow at a considerable CAGR over the forecast period. The primary factor supporting the regional market growth includes the growing the aging population, increasing incidence of neurovascular diseases such as brain aneurysm, carotid stenosis, and stroke, which increases the requirement of neurovascular embolization devices in Noth America. According to the Centers for Disease Control and Prevention (CDC), in 2022, yearly more than 795,000 people in the US encountered with a stroke. About 610,000 of these are first or new strokes. About 185,000 strokes nearly 1 in 4 are in people who have had a previous stroke. About 87.0% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. Every 40 seconds, someone in the US has a stroke. Every 3 minutes and 14 seconds, someone dies of a stroke.

Market Players Outlook

The major companies serving the global neurovascular embolization devices market include B. Braun Melsungen AG, Cerenovus Inc., Medtronic plc, Stryker Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, Fluidx Medical Technology, Inc. released the IMPASS Embolic Device in in-vivo research related to middle meningeal artery (MMA) embolization which can be used to treat chronic subdural hematomas (CSDH) on the surface of the brain.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global neurovascular embolization devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. B. Braun Melsungen AG
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Cerenovus Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Medtronic plc
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Stryker Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Neurovascular Embolization Devices Market by Product
    • 4.1.1. Embolic Coils
    • 4.1.2. Flow Diversion Devices
  • 4.2. Global Neurovascular Embolization Devices Market by End-Use
    • 4.2.1. Hospitals
    • 4.2.2. Specialty Clinics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Acandis GmbH
  • 6.2. Balt Extrusion SA
  • 6.3. Boston Scientific Corp.
  • 6.4. DePuy Synthes (Johnson & Johnson Services, Inc.)
  • 6.5. Integra Lifesciences Holdings Corp.
  • 6.6. MicroVention Inc.
  • 6.7. Penumbra Inc.
  • 6.8. Phenox GmbH
  • 6.9. Resonetics LLC
  • 6.10. Spartan Micro, Inc.
  • 6.11. Terumo Medical Corp.

LIST OF TABLES

  • 1. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL NEUROVASCULAR EMBOLIC COILS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL FLOW DIVERSION NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 5. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR SPECIALTY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 9. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 11. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 12. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 13. EUROPEAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 14. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 17. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL NEUROVASCULAR EMBOLIC COILS MARKET SHARE, 2022 VS 2030 (%)
  • 3. GLOBAL FLOW DIVERSION NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET RESEARCH AND ANALYSIS BY END-USE, 2022 VS 2030 (%)
  • 5. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES FOR SPECIALTY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. US NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 9. CANADA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 10. UK NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. FRANCE NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. GERMANY NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. ITALY NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. SPAIN NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. REST OF EUROPE NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. INDIA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CHINA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. JAPAN NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SOUTH KOREA NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF ASIA-PACIFIC NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD NEUROVASCULAR EMBOLIZATION DEVICES MARKET SIZE, 2022-2030 ($ MILLION)